MeiraGTx Holdings (MGTX) Asset Writedowns and Impairment (2023 - 2024)

MeiraGTx Holdings (MGTX) posted Asset Writedowns and Impairment of -$409000.0 for Q4 2024, down 2456.25% on a QoQ basis from -$16000.0 in Q3 2024, and down 438.16% year-over-year from $120949.4 in Q1 2024.

MeiraGTx Holdings (MGTX) Asset Writedowns and Impairment (2023 - 2024) Analysis & Trends

MeiraGTx Holdings' Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at -$409000.0 for Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 MeiraGTx Holdings 997.33 Mn 931.40 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -409,000.00
Dec 31, 2024 -409,000.00
Sep 30, 2024 -16,000.00
Sep 30, 2024 -16,000.00
Dec 31, 2023 -76,000.00
Dec 31, 2023 -76,000.00